(Q46421625)

English

Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Maryse Lapeyre-Mestre

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

object named as

Vincent Pradel

3

0 references

author name string

Elisabeth Frauger

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Vanessa Pauly

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Frank Rouby

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Jocelyne Arditti

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Xavier Thirion

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Joëlle Micallef

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

publication date

16 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Fundamental and Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

25

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

633-641

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Sleep and aging: 2. Management of sleep disorders in older people

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Recent developments in drug therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Subtypes of nonmedical prescription drug misuse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Clonazepam withdrawal in 13 patients with active epilepsy and drug side effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Clonazepam prescribing patterns and abuse by methadone patients in a medical center setting.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

[First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Comparison of methadone and high dosage buprenorphine users in French care centres

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Buprenorphine prescription by general practitioners in a French region.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Misuse of trihexyphenidyl (Artane, Parkinane): recent trends

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Principles of laboratory assessment of drug abuse liability and implications for clinical development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Assessing abuse liability in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

ABC of mental health. Addiction and dependence--I: Illicit drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Abuse liability of flunitrazepam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Hair analysis by liquid chromatography-tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003-May 2004 in metropolitan Paris

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Chemical submission: results of 4-year French inquiry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00882.X

21 January 2018

Anticonvulsant drugs for acute and chronic pain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001133.PUB2

Identifiers

10.1111/J.1472-8206.2010.00882.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21077937

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46421625&oldid=2110523060"